Investigation into CarMax, Inc. for Potential Violations of Federal Securities Laws

Leading securities law firm Bleichmar Fonti & Auld LLP has announced an investigation into CarMax, Inc. for potential violations of the federal securities laws. The investigation follows CarMax's reported sales declines, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units for fiscal Q2 2025. The Company attributes the decline to a "pull forward" in demand due to the announcement of tariffs. As a result, the price of CarMax stock fell $11.45 per share, or roughly 20%, from $57.05 per share on September 24, 2025, to $45.60 per share on September 25, 2025.

Key Takeaways:

• CarMax, Inc. is being investigated by Bleichmar Fonti & Auld LLP for potential violations of the federal securities laws.
• The investigation follows CarMax's reported sales declines in fiscal Q2 2025, including a 5.4% decline in retail used unit sales.
• CarMax attributes the decline to a "pull forward" in demand due to the announcement of tariffs.
• The price of CarMax stock fell $11.45 per share, or roughly 20%, from $57.05 per share on September 24, 2025, to $45.60 per share on September 25, 2025.
• Shareholders who invested in CarMax are encouraged to submit their information to the firm, which will seek court approval for any potential fees and expenses.
• The firm has a history of success in securities class actions, including recovering over $900 million in value from Tesla, Inc.'s Board of Directors.

Statistics:

• 5.4% decline in retail used unit sales
• 6.3% decline in comparable store used unit sales
• 2.2% decline in wholesale units
• $11.45 per share decline in stock price
• 20% decline in stock price

Sources:

• Bleichmar Fonti & Auld LLP press release, October 13, 2025
• Newsfile Corp., October 13, 2025
• CarMax, Inc. (NYSE: KMX)
• Tesla, Inc.
• Teva Pharmaceutical Ind. Ltd.